Last reviewed · How we verify
A Clinical Study to Investigate if a Single Dose of an Approved Drug Product (Glycopyrrolate Inhalation Solution) Reduces Trapped Air in the Lungs of Participants With Chronic Obstructive Pulmonary Disease.
A clinical study to investigate if a single dose of an approved drug product (glycopyrrolate Inhalation Solution) reduces trapped air in the lungs of participants with chronic obstructive pulmonary disease. This study is accepting male and female participants over the age of 40. The study will be conducted at one site located in the United States.
Details
| Lead sponsor | Sunovion Respiratory Development Inc. |
|---|---|
| Phase | PHASE4 |
| Status | COMPLETED |
| Enrolment | 44 |
| Start date | Thu Nov 07 2019 00:00:00 GMT+0000 (Coordinated Universal Time) |
| Completion | Tue Mar 31 2020 00:00:00 GMT+0000 (Coordinated Universal Time) |
Conditions
- Chronic Obstructive Pulmonary Disease (COPD)
Interventions
- Glyocopyrrolate Inhalation Solution administered by Magnair
- Placebo administered by Magnair
Countries
United States